Compare Quest Diagnostics Inc (DGX) vs Lennar Corporation (LEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quest Diagnostics Inc vs Lennar Corporation — how do they compare? Quest Diagnostics Inc trades at $237.5 (market cap $26.21B), while Lennar Corporation trades at $87.46 (market cap $21.05B). The key difference: Quest Diagnostics Inc is the larger of the two by market cap, and Lennar Corporation pays the higher dividend (2.28%). Which is the better fit depends on your goals.
| DGX | LEN | |
|---|---|---|
Market Cap | $26.21B | $21.05B |
Sector | Health | Consumer Cyclical |
52-Week High | $238.50 | $142.40 |
52-Week Low | $173.49 | $81.84 |
Enterprise Value | $31.97B | $24.93B |
Dividend Yield | 1.45% | 2.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Quest Diagnostics Inc
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →About Lennar Corporation
Lennar is the second-largest public homebuilder in the United States. The company's homebuilding operations target first-time, move-up, and active adult homebuyers mainly under the Lennar brand name. Lennar's financial-services segment provides mortgage financing and related services to its homebuyers. Miami-based Lennar is also involved in multifamily construction and has invested in numerous housing-related technology startups.
Read more on LEN →
